Proposed Drug Price Reform would Short-Change Rare Disease Patients
By Kenneth E. Thorpe
A prominent healthcare watchdog claims it has found the solution to high drug prices.
For years, the nonprofit Institute for Clinical and Economic Review has analyzed and rated the cost-effectiveness of new drugs. ICER wants insurers and government programs to use these ratings to determine which medicines are worth covering. If health plans only cover drugs that provide a good "value" to patients and taxpayers, ICER believes drug expenditures would plummet.
This approach probably would cut short-term spending -- but it'd also endanger patients, especially those with rare diseases that afflict fewer than 200,000 people. Millions of Americans could lose access to life-enhancing drugs. And research into rare disease treatments would grind to a halt.
For each drug it evaluates, ICER offers a suggested price range based on how many additional months or years of good health the treatment provides to patients. In the United States, ICER recommends that drugs not cost more than $175,000 for each "quality adjusted life year" -- 12 months of good health -- they deliver.
Rare disease drugs rarely meet ICER's standards. Four out of the five rare disease therapies that ICER assessed between December 2014 and August 2018 were deemed low value.
Consider revolutionary treatments for spinal muscular atrophy or SMA, the leading genetic cause of death for infants. The FDA approved the first therapy for SMA in 2016. Parents credit the drug with saving their children and enabling them to hit developmental milestones that were previously unreachable.
ICER recently determined the therapy fell short of "traditional cost-effectiveness" thresholds. To fit within those thresholds, its price would have to drop up to 90 percent.
So are these treatments overpriced? Not at all.
On average, it costs $2.6 billion to bring a new drug to market. If public and private health plans used ICER's assessments to deny coverage to certain medicines, drug researchers would have little incentive to develop new therapies.
This is especially true when it comes to drugs for rare diseases.
When companies successfully create rare disease drugs, they must set prices high enough to recover their development costs from a small patient population. As a result, these treatments cost more per dose than traditional drugs, whose costs can be spread over millions of customers.
ICER doesn't sufficiently account for this difference between mass-market and rare disease drugs.
Despite its limitations, ICER's approach appeals to policymakers and insurers who want to cut drug spending. They could point to an ICER analysis as an "objective" reason to not cover certain drugs.
This is already happening in the United Kingdom. The National Institute for Health and Care Excellence -- which uses a framework somewhat similar to ICER's -- routinely recommends denying patients access to potentially life-saving drugs for conditions ranging from cancer to cystic fibrosis.
If the United States adopted a similar approach, 30 million rare disease patients could face similar barriers to treatment almost immediately.
The long-term effects would be even worse. If insurers and government programs stop paying for rare disease treatments, the financial incentive to develop these drugs would evaporate. Research into thousands of rare diseases would dry up, along with patients' hope for a long, healthy life.
Lowering drug spending is a worthy goal. But not at the expense of stifling research and condemning millions of patients.
Kenneth E. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.
More Resources
Unable to open RSS Feed $XMLfilename with error HTTP ERROR: 404, exiting
More Medicine Information:
Related Articles
Lunesta Pregnancy And Breastfeeding
Lunesta is a newly released sleeping pill. Marketed as a revolutionary sleep aid, Lunesta is the only medication approved by the FDA for long term treatment of insomnia symptoms.
Marketing Authorisation - Medicinal Products
Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.
Are Drug Companies Destroying The U.S. Health Care System?
The U.S.
A Closer Look at Neck Pain Relief
Neck pain afflicts many people at some point in their life - two-thirds of American adults report having experienced at least one incidence of neck pain in their lives. You can strain your neck during exercise, at work, or even something as simple as turning over in your sleep.
"Winning the War Against Rheumatoid Arthritis"
RA is a condition that forces half of patients to become disabled from the work force within five to ten years? and reduces life expectancy by as much as 18 years. RA affects about one per cent of the world's adult population, most commonly women between the ages of 30 and 50.
When Your John Doe Is Homeless
The patient, known only as John Doe, was difficult to see under the hodgepodge of tubing, the quiet clicking of the ventilator the room's only sound.From all appearances he was homeless, but in the opinion of his nurse, who has had vast experience in dealing with patients just like him, everyone has a mother or a father, a son or a daughter, and homeless or not, it's a nurse's responsibility to do what he can to help find them.
"Get Rid of Tendonitis ? Now!" Advice From An Expert?
Tendons are ropes of fibrous tissue that connect muscles to bones. It is this connection that permits joint motion.
The Truth about C Reactive Protein and Cholesterol Lowering Drugs
You might disagree, but hear me out on this..
Chinese Medicine
Chinese Medicine, over 2000 years old, is an ancient form of medicine. Consisting of acupuncture, moxibustion (moxibustion - using material made up of "moxa-wool," in a form of a cone or stick; moxibustion is used to treat and prevent disease by applying heat to pints or certain locations of the human body), herbal medicine, acupressure, cupping, therapeutic exercise and nutrition, traditional Chinese medicine is notated by its principle of internal balance and harmony, or "chi," (life force) regulation through energy channels.
Healthcare Providers -- Its Time for Your Physical
I think this is a good time for a checkup, or physical as it is termed in the healthcare industry. I mean this is a good time to check the health of your site or setting.
Anxiety Management With Prescription BuSpar: Don't Worry, Be Happy
We've all had one of those weeks: the washing machine overflows, the dog forgets his housetraining and the toddler her toilet training, the boss is going through a divorce and making everyone miserable. And you feel like you just don't know how to handle it all.
Bextra and Vioxx -- Tips for Arthritis Relief Without Them
The recent withdrawal of Vioxx and Bextra from the marketplace, due to concerns over unwanted side effects, has many arthritis sufferers concerned. These drugs, which belong to a powerful class of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, are quite effective at fighting the pain and inflammation of arthritis.
Jet Lag Pills - Panacea or Placebo Effect?
We live in an age that demands an instant cure for every conceivable ailment under the sun and so it's no surprise that jet lag has joined the band of conditions for which there is the promise of a cure in the form of a pill. But can a pill really provide the panacea to jet lag, or are the results of taking such pills nothing more than imagined.
Bulk Forming Drugstore Laxatives
There are five basic types of drugstore laxatives you should be aware of. Some of these laxatives can be dangerous to use.
Building A Medical Spa Inside Your Existing Medical Practice
The physicians conundrum:Everywhere, physicians are contemplating or engaged in expanding into the "medical spa" market. Seduced by the media buzz around this hot new phenomenon, many doctors see the medical spa as a means boosting their income and eliminating the growing grind and countless headaches of their daily practice.
Is Anxiety Ruling Your Life?
Anxiety is the most frequently occurring mental health disorder in the United States, according to the US Surgeon General. There are millions of people who are diagnosed with it every year.
Online Pharmacy Watch: DEA Does Spring Cleaning Of Illegal Internet Pharmacies
Since early 2004, it has become more apparent every day that the online pharmacy industry is being destroyed. Who is doing such damage to bring the industry crashing down, you ask? So far, the people responsible are savvy businessmen who are using their skills to create temporary safety nets for black-hat operations using loopholes in international security.
The Neurological Exam: Evaluating the Master Organ
How does a mind contemplate itself? That's a philosophical question I'll leave to minds smarter than mine, but what I can tell you is how to examine the brain and other parts of the nervous system.Most people are familiar with how doctors examine a heart or set of lungs.
You Are Getting Very Sleepy....The Truth about Hypnosis
A hypnotic "trance" is not something that is foreign to us--we've all been so absorbed in thought while reading a book or watching a movie that we fail to notice what is happening around us. These focused states of attention are similar to hypnosis.
195,000 Die Annually From Hospital Mistakes
It just seemed too absurd to be true, but there it was in the August 2, 2004 edition of Newsweek I picked up the other day: "According to HealthGrades, the health-care-rating organization that conducted the study, needless deaths averaged 195,000 a year in 2000, 2001, and 2002. 'That's the equivalent of 390 jumbo jets full of people dying each year,' says Dr.